TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vaccindirekt i Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
41,716
|
37,369
|
29,580 |
| Financial expenses |
26
|
11
|
12 |
| Earnings before taxes |
5,413
|
7,251
|
6,328 |
| EBITDA |
5,297
|
7,472
|
6,634 |
| Total assets |
15,124
|
15,692
|
9,554 |
| Current assets |
4,765
|
5,975
|
7,702 |
| Current liabilities |
5,092
|
5,319
|
3,916 |
| Equity capital |
9,245
|
9,553
|
5,242 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
181
|
188
|
163 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
61.1%
|
60.9%
|
54.9% |
| Turnover per employee |
230
|
199
|
181 |
| Profit as a percentage of turnover |
13.0%
|
19.4%
|
21.4% |
| Return on assets (ROA) |
36.0%
|
46.3%
|
66.4% |
| Current ratio |
93.6%
|
112.3%
|
196.7% |
| Return on equity (ROE) |
58.6%
|
75.9%
|
120.7% |
| Change turnover |
5,618
|
7,702
|
7,841 |
| Change turnover % |
16%
|
26%
|
36% |
| Chg. No. of employees |
-7
|
25
|
-3 |
| Chg. No. of employees % |
-4%
|
15%
|
-2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.